Zekun Li

687 total citations
21 papers, 461 citations indexed

About

Zekun Li is a scholar working on Molecular Biology, Immunology and Molecular Medicine. According to data from OpenAlex, Zekun Li has authored 21 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 4 papers in Immunology and 3 papers in Molecular Medicine. Recurrent topics in Zekun Li's work include Antibiotic Resistance in Bacteria (3 papers), Ubiquitin and proteasome pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Zekun Li is often cited by papers focused on Antibiotic Resistance in Bacteria (3 papers), Ubiquitin and proteasome pathways (3 papers) and Histone Deacetylase Inhibitors Research (3 papers). Zekun Li collaborates with scholars based in China, Australia and United States. Zekun Li's co-authors include Zhaoxin Tang, Feiyang Ma, Shixin Xu, Lu Zhang, Qiwen Yang, Lingxian Yi, Yuping Cao, Jian–Hua Liu, Roger L. Nation and Hongjuan Cui and has published in prestigious journals such as Nature Communications, The Science of The Total Environment and International Journal of Molecular Sciences.

In The Last Decade

Zekun Li

17 papers receiving 455 citations

Peers

Zekun Li

POLLU

PHARM

Elias Dahdouh Spain

Maria Laura Ciusa United Kingdom

María Getino United Kingdom

Aparna Singh India

Tengfei Dou China

Shixiong Yan China

Sameh AbdelGhani Egypt

Jamileh Nowroozi Iran

Qidi Zhang China

Elias Dahdouh Spain

Zekun Li

272 ×1.6

117 ×0.8

101 ×0.9

POLLU

63 ×0.7

75 ×1.5

PHARM

Citations per year, relative to Zekun Li Zekun Li (= 1×) peers Elias Dahdouh

Countries citing papers authored by Zekun Li

Since Specialization

Citations

This map shows the geographic impact of Zekun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zekun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zekun Li more than expected).

Fields of papers citing papers by Zekun Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zekun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zekun Li. The network helps show where Zekun Li may publish in the future.

Co-authorship network of co-authors of Zekun Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zekun Li. A scholar is included among the top collaborators of Zekun Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zekun Li. Zekun Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Zekun, Lu Zhang, Haifeng Zhang, et al.. (2025). Molecular targets of neuroplasticity in ischemic stroke: insights from GEO database, single-cell analysis and immune infiltration analysis. Frontiers in Aging Neuroscience. 17. 1561282–1561282.

Li, Zekun, et al.. (2025). Decoding Alzheimer's Disease With Depression: Molecular Insights and Therapeutic Target. Journal of Cellular and Molecular Medicine. 29(5). e70454–e70454.

Li, Zekun, et al.. (2025). Rapamycin ameliorates senescence of periodontal ligament stem cells and promotes their osteogenesis via the PI3K/AKT pathway. International Immunopharmacology. 153. 114517–114517. 2 indexed citations

Zhang, Shanshan, et al.. (2025). Global, regional and national level burden of bulimia nervosa from 1990 to 2021 and their projections to 2030: analysis of the global burden of disease study. Journal of Eating Disorders. 13(1). 110–110.

Wang, Danni, et al.. (2025). The value of coimmunoprecipitation (Co-IP) assays in drug discovery. Expert Opinion on Drug Discovery. 20(7). 859–872. 2 indexed citations

Zhang, Peng, Lele Liu, Xiang Zhao, et al.. (2024). Enhancing homology-directed repair efficiency with HDR-boosting modular ssDNA donor. Nature Communications. 15(1). 6843–6843. 11 indexed citations

Liu, Xinjuan, et al.. (2024). Metformin-mediated effects on mesenchymal stem cells and mechanisms: proliferation, differentiation and aging. Frontiers in Pharmacology. 15. 1465697–1465697. 4 indexed citations

Li, Zekun, Shu Meng, Tong Yang, et al.. (2024). An atlas of cell-type-specific interactome networks across 44 human tumor types. Genome Medicine. 16(1). 30–30. 4 indexed citations

Li, Zekun, et al.. (2024). Identification and analysis of key immunity-related genes in experimental ischemic stroke. Heliyon. 10(17). e36837–e36837.

10.

Li, Zekun, Qiuyu Wu, Jia Yu, et al.. (2024). Design and Synthesis of 7-Oxabicyclo[2.2.1]heptane-2,3-dicarboxylic Acid Derivatives as PP5 Inhibitors To Reverse Temozolomide Resistance in Glioblastoma Multiforme. Journal of Medicinal Chemistry. 67(17). 15691–15710. 2 indexed citations

11.

Li, Zekun, Sizhe Liu, Xiang Zhao, et al.. (2024). Schlafen 11 triggers innate immune responses through its ribonuclease activity upon detection of single-stranded DNA. Science Immunology. 9(96). eadj5465–eadj5465. 13 indexed citations

12.

Zhang, Mengzhe, et al.. (2023). A cuproptosis-related lncRNA signature-based prognostic model featuring on metastasis and drug selection strategy for patients with lung adenocarcinoma. Frontiers in Pharmacology. 14. 1236655–1236655. 2 indexed citations

13.

Chen, Xiaomei, Jun Guo, Zekun Li, et al.. (2023). Toxicity of o-phenylphenol on craniofacial cartilage development through ROS-induced oxidative stress in zebrafish embryos. The Science of The Total Environment. 892. 164396–164396. 10 indexed citations

14.

Li, Zekun, et al.. (2023). Targeting phosphatases: From molecule design to clinical trials. European Journal of Medicinal Chemistry. 264. 116031–116031. 12 indexed citations

15.

Li, Zekun, et al.. (2023). Histone demethylase KDM4B accelerates the progression of glioblastoma via the epigenetic regulation of MYC stability. Clinical Epigenetics. 15(1). 192–192. 6 indexed citations

16.

Lan, Chungen, Bo Ni, Tiansuo Zhao, et al.. (2022). An Integrative Pan-Cancer Analysis Revealing MLN4924 (Pevonedistat) as a Potential Therapeutic Agent Targeting Skp2 in YAP-Driven Cancers. Frontiers in Genetics. 13. 866702–866702. 3 indexed citations

17.

Yang, Qiwen, Jason M. Pogue, Zekun Li, et al.. (2020). Agents of Last Resort. Infectious Disease Clinics of North America. 34(4). 723–750. 30 indexed citations

18.

Ma, Feiyang, Shixin Xu, Zhaoxin Tang, Zekun Li, & Lu Zhang. (2020). Use of antimicrobials in food animals and impact of transmission of antimicrobial resistance on humans. Biosafety and Health. 3(1). 32–38. 252 indexed citations

19.

Wang, Huiyu, Changbei Ma, Zekun Li, & Kefeng Wu. (2019). An exonuclease-assisted fluorescence sensor for assaying alkaline phosphatase based on SYBR Green I. Molecular and Cellular Probes. 45. 26–30. 9 indexed citations

20.

Li, Zekun, Yuping Cao, Lingxian Yi, Jian–Hua Liu, & Qiwen Yang. (2019). Emergent Polymyxin Resistance: End of an Era?. Open Forum Infectious Diseases. 6(10). 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact